Sapience Investments LLC bought a new stake in Acadia Healthcare Company Inc (NASDAQ:ACHC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 315,010 shares of the company’s stock, valued at approximately $10,279,000. Acadia Healthcare comprises 1.4% of Sapience Investments LLC’s investment portfolio, making the stock its 29th biggest position. Sapience Investments LLC owned 0.36% of Acadia Healthcare at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in ACHC. State of Alaska Department of Revenue purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $150,000. CIBC World Markets Inc. purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $236,000. Arthur Zaske & Associates LLC purchased a new stake in shares of Acadia Healthcare in the third quarter valued at approximately $283,000. Parametrica Management Ltd purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $327,000. Finally, Trustcore Financial Services LLC purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at approximately $335,000.
A number of analysts have commented on the company. Royal Bank of Canada reiterated a “buy” rating and set a $45.00 target price on shares of Acadia Healthcare in a research report on Tuesday, February 27th. Cantor Fitzgerald upgraded Acadia Healthcare from a “neutral” rating to an “overweight” rating in a research report on Sunday, February 25th. Robert W. Baird set a $42.00 target price on Acadia Healthcare and gave the stock a “hold” rating in a research report on Thursday, February 22nd. BidaskClub upgraded Acadia Healthcare from a “hold” rating to a “buy” rating in a research report on Thursday, February 22nd. Finally, Credit Suisse Group reiterated a “neutral” rating and set a $40.00 target price (up from $35.00) on shares of Acadia Healthcare in a research report on Thursday, February 22nd. Six investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $44.50.
Acadia Healthcare Company Inc (NASDAQ:ACHC) opened at $41.10 on Monday. Acadia Healthcare Company Inc has a 1-year low of $26.92 and a 1-year high of $54.34. The firm has a market capitalization of $3,614.75, a price-to-earnings ratio of 17.79, a PEG ratio of 1.34 and a beta of 0.69. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.25 and a quick ratio of 1.25.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.07. Acadia Healthcare had a return on equity of 8.16% and a net margin of 6.92%. The company had revenue of $724.50 million during the quarter, compared to analysts’ expectations of $713.20 million. During the same period in the previous year, the firm posted $0.59 earnings per share. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. equities research analysts anticipate that Acadia Healthcare Company Inc will post 2.45 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This story was first reported by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/03/12/sapience-investments-llc-takes-position-in-acadia-healthcare-company-inc-achc.html.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.